Keyphrases
Anticonvulsant
21%
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
33%
Chronic Kidney Disease
60%
Cimetidine
16%
Confidence Interval
16%
Creatinine
17%
Denmark
39%
Diabetic Nephropathy
20%
Dialysis
18%
Egfr
27%
End-stage Renal Disease
92%
Estimated Glomerular Filtration Rate
37%
Ezetimibe
18%
First Week
16%
Glomerular Filtration Rate
49%
Glucagon
39%
Glucagon-like
28%
Glucose-dependent Insulinotropic Polypeptide
17%
Growth Hormone
16%
Hemodialysis Patients
16%
Insulin Secretion
30%
Insulin Sensitivity
22%
Investigator-initiated
16%
Kidney Transplantation
49%
LDL Cholesterol
20%
Liraglutide
16%
Lithium
37%
Mannose-binding Lectin
16%
National Cohort Study
20%
Non-diabetic
27%
Orosomucoid
25%
Placebo
33%
Plasma Concentration
15%
Pre-diabetes (pre-DM)
26%
Preeclampsia
26%
Pulse Wave Velocity
15%
Randomized Placebo-controlled Trial
16%
Rapid Decline
16%
Rate Ratio
18%
Renal Denervation
16%
Renal Function
42%
Renal Protection
16%
Simvastatin
15%
Transplantation
39%
Type 1 Diabetes Mellitus (T1DM)
39%
Type 2 Diabetes Mellitus (T2DM)
23%
Type 2 Diabetic Patients
48%
Type I Diabetes
39%
Uremic Patients
47%
Urinary Albumin Excretion
23%
Medicine and Dentistry
Chronic Kidney Disease
31%
Diabetes
30%
Diabetes Mellitus
78%
Diabetic Nephropathy
16%
End Stage Renal Disease
100%
Glomerular Filtration Rate
45%
Glucagon
16%
Glucagon Like Peptide 1
20%
Human immunodeficiency virus
16%
Impaired Glucose Tolerance
24%
Incretin
15%
Insulin Dependent Diabetes Mellitus
30%
Insulin Release
22%
Insulin Sensitivity
23%
Kidney Function
58%
Kidney Transplantation
60%
Mannose Binding Lectin
16%
Nephropathy
18%
Orosomucoid
16%
Patient with Type 2 Diabetes
18%
Polycystic Kidney Disease
39%
Pre-Eclampsia
18%
Prevalence
15%
Pulse Wave Velocity
21%
Renal Protection
16%
Renal Replacement Therapy
20%
Urinary System
32%
